Cellular delivery of modified peptide nucleic acids: a review
Author:
Affiliation:

Clc Number:

Fund Project:

The Natural Science Major Project of Chongqing Natural Science Foundation (No. cstc2013jjB0011), Chongqing Application Development Project (No. cstc2013yykfB10013), Agricultural Science and Technology Achievements Funds of Sichuan Province (No. 14NZ0027-1).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Peptide nucleic acid (PNA) is a DNA surrogate in which the phosphate deoxyribose backbone of DNA is replaced by repeating N-(2-aminoethyl)glycine units. PNA can hybridize to the complementary DNA and RNA with higher affinity than their oligonucleotide counterparts. This character of PNA not only makes it a new tool for the studies of molecular biology but also the potential candidate for gene-targeting drugs. The non-ionic backbone of PNA leads to stable hybrids with the nucleic acids, but at the same time, the neutral backbone results in poor cellular uptake. To address this problem, studies on modified PNA progress rapidly in recent years. We reviewed literature reports combined with our study about the delivery methods, including backbone modified PNA and PNA-ligand conjugates, and the cellular uptake of modified PNA. In addition, we summarized the problems and future prospect of the cellular delivery of modified PNA.

    Reference
    Related
    Cited by
Get Citation

刘春冬,王建华,曾芳. 修饰性肽核酸的细胞转运[J]. Chinese Journal of Biotechnology, 2016, 32(3): 292-305

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 15,2015
  • Revised:
  • Adopted:
  • Online: March 03,2016
  • Published:
Article QR Code